ACAD

ACADIA PHARMACEUTICALS INC

Biotechnology · Biotechnology

$225.13 sample

-2.08 (-0.92%) 1D

Market cap

$665.4B

Price as of

2026-10-22

Latest filing

8-K

Alerts

8

Price$225.13 -5.92% 3M daily closessample

239.30212.80

2026-07-272026-08-182026-09-092026-09-302026-10-22

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider sell: Chief Financial Officer
Oct 14INSInsider sell: General Counsel
Oct 09INSInsider buy: 10% owner
Oct 01INSInsider sell: General Counsel
Sep 28INSInsider sell: 10% owner
Sep 23INSInsider sell: General Counsel
Sep 17INSInsider sell: 10% owner
Sep 08INSInsider sell: Chief Executive Officer

Sign up to see the real ACAD record →

Company facts

SEC EDGAR registration

Name: ACADIA PHARMACEUTICALS INC
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -56sample, -100 to +100
Reporting currency: USD

Who is positioning in ACAD

sample

Insiders: 14 insider transactions over 90 days, net selling, $554.8M
Congress: 2 members traded over 90 days
Institutions · 13F: 22 funds hold $14.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$19.1B +14.7% y/y

Q4 2024Q3 2026

Inventory$10.7B +12.9% y/y

Q4 2024Q3 2026

Accounts receivable$8.0B +8.5% y/y

Q4 2024Q3 2026

Total debt$22.3B +17.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $358.4B +6.3% 3M
Sample peer B: $414.0B +7.9% 3M
Sample peer C: $359.6B -0.5% 3M
Sample peer D: $510.5B +12.0% 3M
Sample peer E: $600.3B -6.3% 3M